cme group inc. - CME

CME

Close Chg Chg %
306.31 1.39 0.45%

Closed Market

307.70

+1.39 (0.45%)

Volume: 2.68M

Last Updated:

Nov 20, 2026, 4:00 PM EDT

Company Overview: cme group inc. - CME

CME Key Data

Open

$310.46

Day Range

306.88 - 313.10

52 Week Range

218.33 - 329.16

Market Cap

$111.05B

Shares Outstanding

357.93M

Public Float

352.96M

Beta

0.18

Rev. Per Employee

N/A

P/E Ratio

25.44

EPS

$12.28

Yield

368.91%

Dividend

$1.30

EX-DIVIDEND DATE

Dec 11, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

1.97M

 

CME Performance

1 Week
 
-3.27%
 
1 Month
 
0.61%
 
3 Months
 
11.85%
 
1 Year
 
12.62%
 
5 Years
 
37.73%
 

CME Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 21
Full Ratings ➔

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 318.063
Number of Ratings 21 Current Quarters Estimate 3.034
FY Report Date 12 / 2026 Current Year's Estimate 12.404
Last Quarter’s Earnings 3.02 Median PE on CY Estimate N/A
Year Ago Earnings 11.20 Next Fiscal Year Estimate 13.259
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 14 12 17 17
Mean Estimate 3.03 3.32 12.40 13.26
High Estimates 3.28 3.60 12.66 13.70
Low Estimate 2.92 3.05 12.29 12.38
Coefficient of Variance 2.95 5.77 0.68 2.67

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 8 8 6
OVERWEIGHT 4 3 3
HOLD 7 7 7
UNDERWEIGHT 1 1 1
SELL 1 1 2
MEAN Overweight Overweight Overweight

Insider Actions for Cme Group Inc. - CME

Date Name Shares Transaction Value
Nov 20, 2026 Terrence A. Duffy Chairman and CEO; Director 35,442 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $310.18 per share 10,993,399.56
Nov 20, 2026 Terrence A. Duffy Chairman and CEO; Director 52,442 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $308.54 per share 16,180,454.68
Nov 20, 2026 John Marchese Sr MD, General Counsel 2,943 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $310.75 per share 914,537.25
Nov 11, 2026 Daniel George Kaye Director 4,313 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $304.17 per share 1,311,885.21
Nov 4, 2026 Howard J. Siegel Director 19,873 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $303 per share 6,021,519.00
Oct 28, 2026 Sunil Cutinho Chief Information Officer 20,037 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $298.7 per share 5,985,051.90
Sep 15, 2026 Elizabeth A. Cook Director 17,916 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $280.11 per share 5,018,450.76
Mar 18, 2026 Jonathan Marcus Sr MD General Counsel 10,483 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $311.4 per share 3,264,406.20
Mar 18, 2026 Tim McCourt Sr MD Global Head Equity & FX 12,202 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $311.4 per share 3,799,702.80
Mar 18, 2026 Tim McCourt Sr MD Global Head Equity & FX 15,012 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $311.4 per share 4,674,736.80
Mar 18, 2026 Sunil Cutinho Chief Information Officer 23,586 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $311.4 per share 7,344,680.40
Mar 18, 2026 Jack J. Tobin MD Chief Accounting Officer 25,409 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $311.4 per share 7,912,362.60
Mar 18, 2026 Jack J. Tobin MD Chief Accounting Officer 25,588 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $311.4 per share 7,968,103.20
Mar 18, 2026 Julie M. Winkler Sr MD Chief Commercial Officer 30,110 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $311.4 per share 9,376,254.00
Mar 18, 2026 Julie M. Winkler Sr MD Chief Commercial Officer 33,768 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $311.4 per share 10,515,355.20
Mar 18, 2026 Kendal Vroman Chief Transformation Officer 18,851 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $311.4 per share 5,870,201.40
Mar 18, 2026 Kendal Vroman Chief Transformation Officer 21,986 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $311.4 per share 6,846,440.40
Mar 18, 2026 Hilda Harris Piell Sr MD & Chief HR Officer 33,455 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $311.4 per share 10,417,887.00
Mar 18, 2026 Hilda Harris Piell Sr MD & Chief HR Officer 36,494 Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $311.4 per share 11,364,231.60
Mar 18, 2026 Derek L. Sammann Sr MD Gl Hd Commodities Mkts 13,312 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $311.4 per share 4,145,356.80

Cme Group Inc. in the News

CME denies CBOE merger report

Derivatives exchange giant CME Group has forcefully denied a report that it is in talks to acquire smaller Cboe Global Markets.